FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.
Fed cuts rates, but two officials dissent, as policymakers debate next steps amid data uncertainty and a government shutdown.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.
Fed cuts rates, but two officials dissent, as policymakers debate next steps amid data uncertainty and a government shutdown.